The global trimebutine market is expanding through the availability of oral formulations, including tablets and other preparations. These dosage forms offer practical administration options and allow pharmaceutical manufacturers to serve different patient requirements and prescribing preferences. The trimebutine market size is expected to reach US$ 272.14 million by 2034 from US$ 161.21 million...